Dexcom | DXCM - SCHULD

Aktienkurs
67.54
Täglich Wechseln
0.22 0.33%
Monatlich
-6.54%
Jährlich
-7.96%
Q1 Prognose
62.30




SCHULD Veränderung Datum
Abbott USD 12.94B 496M 2025-09
Align Technology USD 121.27M 1.75M 2025-09
AtriCure USD 76.73M 521K 2025-09
Avanos Medical USD 133.7M 3.6M 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 12.05B 19M 2025-09
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Globus Medical USD 119.34M 1.76M 2025-09
Hologic USD 2.63B 104.3M 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
J&J USD 45.8B 4.97B 2025-09
Masimo USD 586.2M 56M 2025-09
Medtronic USD 29.1B 491M 2025-09
Merit Medical Systems USD 821.15M 599K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
West Pharmaceutical Services USD 202.8M 100K 2025-12
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12